BIOMARIN PHARMACEUTICAL INC: operating_income
| Value | {"amount": -110215000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2012-01-01 – 2012-12-31 |
| Status | current |
| Entity | BIOMARIN PHARMACEUTICAL INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:17:08.038860+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/62737d45-ca16-4943-80c8-cfd298ceac18
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-13-077031Retrieved: 2026-08-19T10:17:08.038860+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001048477/operating-income/2012-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/62737d45-ca16-4943-80c8-cfd298ceac18
History
- no predecessors — first report